Biggest News Aggregation in the World
๐Ÿ“ฐ Scott Kellen News

Page 2 - Scott Kellen News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scott Kellen. Real-time updates on events, politics, business and more.

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

MINNEAPOLIS--(BUSINESS WIRE)--Jul 15, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Companyรขย€ย™s Board of Directors. Amy Burroughs, President and CEO of Cleave Therapeutics, brings over 20 years of experience in business and commercial development, strategy and leadership in the pharmaceutical indust...
United States Rick Pauls Eluminex Biosciences Charles Semba Cathflo Activase Scott Kellen

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results May 5, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--May 5, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter...
United States Rick Pauls Scott Kellen Tim Mccarthy Lifesci Advisors Drug Administration
Source: apnews.com

DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke

Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke March 9, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--Mar 9, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will host a key opinion leader (KOL) webinar on DM199, the C...
United States Kols Scott Kasner Scotte Kasner Scott Kellen Paolo Madeddu Tim Mccarthy
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science